MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cge.13706

Медицинская библиотека · Clinical genetics · 2020

Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction.

Panneman Daan M, Wortmann Saskia B, Haaxma Charlotte A, van Hasselt Peter M, Wolf Nicole I, Hendriks Yvonne, Küsters Benno, van Emst-de Vries Sjenet, van de Westerlo Els, Koopman Werner J H, Wintjes Liesbeth, van den Brandt Frans, de Vries Maaike, Lefeber Dirk J, Smeitink Jan A M, Rodenburg Richard J

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course.

Для цитирования: Panneman Daan M, Wortmann Saskia B, Haaxma Charlotte A, van Hasselt Peter M, Wolf Nicole I, Hendriks Yvonne, Küsters Benno, van Emst-de Vries Sjenet, van de Westerlo Els, Koopman Werner J H, Wintjes Liesbeth, van den Brandt Frans, de Vries Maaike, Lefeber Dirk J, Smeitink Jan A M, Rodenburg Richard J. Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction.. Clinical genetics. 2020. DOI: 10.1111/cge.13706.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.